Chemigenetic voltage indicators

US11385236B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11385236-B2
Application numberUS-201716347765-A
CountryUS
Kind codeB2
Filing dateNov 30, 2017
Priority dateNov 30, 2016
Publication dateJul 12, 2022
Grant dateJul 12, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are a voltage indicator and a method of measuring voltage. The voltage indicator includes a membrane-localized voltage-sensitive protein coupled to a capture protein. The method of measuring voltage includes administering a voltage indicator including a membrane-localized voltage-sensitive protein coupled to a capture protein, and determining changes in fluorescence of a small-molecule fluorescent dye captured by the capture protein.

First claim

Opening claim text (preview).

What is claimed is: 1. A voltage indicator comprising a membrane-localized voltage sensitive protein coupled to a capture protein, wherein the capture protein is covalently or noncovalently labeled with one or more cell permeable fluorescent dyes. 2. The voltage indicator of claim 1 , where the one or more cell permeable fluorescent dyes are azetidine-containing dyes. 3. The voltage indicator of claim 2 , wherein the one or more azetidine-containing dyes are selected from the group consisting of and combinations thereof. 4. The voltage indicator of claim 1 , wherein the voltage sensitive protein is an opsin. 5. The voltage indicator of claim 4 , wherein the opsin is a microbial opsin. 6. The voltage indicator of claim 5 , wherein the microbial opsin is selected from the group consisting of QuasAr2, Ace2N, or a combination thereof. 7. The voltage indicator of claim 1 , wherein the capture protein is covalently labeled by the one or more fluorescent dyes. 8. The voltage indicator of claim 7 , wherein the covalent capture protein is a self-labeling protein tag. 9. The voltage indicator of claim 1 , wherein the capture protein is non-covalently labeled by the one or more fluorescent dyes. 10. The voltage indicator of claim 9 , where in the capture protein is biotin-avidin. 11. The voltage indicator of claim 1 , wherein the membrane-localized voltage sensitive protein comprises at least one voltage sensitive domain selected from the group consisting of an opsin, Ciona intestinalis voltage-sensing domain (CiVSD), Dario rerio voltage-sensing domain (DrVSD), Gallus voltage-sensing domain (GgVSD), and a combination thereof. 12. A method of measuring voltage, the method comprising administering one or more cell permeable fluorescent dyes and a voltage indicator comprising a membrane-localized voltage sensitive protein coupled to a capture protein and determining measuring changes in fluorescence when the one or more cell permeable fluorescent dye are captured by the covalent-capture protein of the voltage. 13. The method of claim 12 , wherein changes in fluorescence are observed with a microscope. 14. The method of claim 12 , wherein the voltage indicator further comprises a linker between the voltage-sensitive protein and the capture protein. 15. The method of claim 14 , further comprising modifying a length of the linker. 16. The method of claim 15 , wherein modifying the length of the linker comprises removing at least one amino acid residue. 17. The method of claim 16 , wherein removing at least one amino acid residue comprises removing between 1 and 22 amino acid residues. 18. The method of claim 15 , wherein modifying the length of the linker modifies the size of a fluorescence response. 19. The method of claim 12 , further comprising measuring changes in voltage based upon changes in fluorescence. 20. The method of claim 12 , wherein the membrane-localized voltage sensitive protein comprises at least one voltage sensitive domain selected from the group consisting of an opsin, Ciona intestinalis voltage-sensing domain (CiVSD), Dario rerio voltage-sensing domain (DrVSD), Gallus voltage-sensing domain (GgVSD), and a combination thereof.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11385236B2 cover?
Provided herein are a voltage indicator and a method of measuring voltage. The voltage indicator includes a membrane-localized voltage-sensitive protein coupled to a capture protein. The method of measuring voltage includes administering a voltage indicator including a membrane-localized voltage-sensitive protein coupled to a capture protein, and determining changes in fluorescence of a small-m…
Who is the assignee on this patent?
Hughes Howard Med Inst
What technology area does this patent fall under?
Primary CPC classification G01N33/582. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).